Setup Menus in Admin Panel


Prometic is a biopharmaceutical company based in Laval, Quebec, Canada. The firm was run by Pierre Laurin, chairman and CEO for 24 years. Since April 2019, it is now managed by Prometic CEO Kenneth Galbraith.

ProMetic develops therapeutics for unsatisfied clinical conditions in the field of hematology, oncology and autoimmune diseases.

ProMetic has also developed a proven technology to isolate and purify proteins. This technology is used by over 40 multinationals for the manufacturing of their own therapeutics: 12 of these companies have their respective drugs approved by the FDA / EMEA

The firm also has offices in Isle of Man, UK and Rockland, Maryland, USA.

Since filming, M. Laurin has left the company in December 2018.

The case was filmed in 2016 in Laval, Quebec, Canada at Prometic’s Canadian facilities.

Course Content

Biopharma, Orphan Drugs, IP, Multinationals, Pharmaceutical industry, Biotech, complex drugs, human plasma, protein isolation, bringing new drugs to market, commercializing drugs, Laval, university research spinoffs, velcro business model, going public, IPO, joint ventures, international partnerships, American Red Cross, climate change disruption, royalty streams, doing business with governments in emerging markets, managing growth.

Technical Specs

Production date: 2017


Pierre Laurin, former Prometic CEO


Special thanks:

Frederic Dumais, former Prometic Senior Director


Executive Producers

Dr Hamid Etemad, McGill University

Hamed Motaghi, Université du Québec en Outaouais



Thierry Harris, Cartouche Media


Creative Director

Melissa Gendron, Cartouche Media


Course Reviews


  • 5 stars0
  • 4 stars0
  • 3 stars0
  • 2 stars0
  • 1 stars0

No Reviews found for this course.

© Copyright 2022. All rights reserved.